Early Interventions Slow the Progression of Cirrhosis After Acute Variceal Bleeding

Background: Acute variceal bleeding (AVB) is a life-threatening manifestation of portal hypertension and an important precipitant of acute decompensation in cirrhosis. The present review evaluates whether early post-bleed interventions can reduce not only early mortality and rebleeding but also the subsequent downward spiral of cirrhosis progression. Methods: A narrative review was conducted using recent society guidance and high-level evidence published mainly between 2022 and 2026, including Baveno VII, AASLD guidance, APASL recommendations, EASL guidance on acute-on-chronic liver failure and TIPS, individual patient data meta-analyses, randomized trials and selected real-world studies. Institutional cohort observations from prior doctoral research were integrated to illustrate long-term clinical trajectories after first and recurrent bleeding. Results: Early standard care - restrictive transfusion, vasoactive therapy, antibiotic prophylaxis and timely endoscopic variceal ligation - acts beyond hemostasis by reducing infection, systemic inflammation, treatment failure and organ dysfunction. In high-risk AVB, pre-emptive TIPS within 24-72 hours is consistently associated with lower rebleeding and improved survival when patients are selected appropriately. Cohort data also indicate that patients with a previous bleeding episode have higher long-term rebleeding and functional deterioration, while stepwise endoscopic-endovascular escalation may reduce recurrent bleeding. Conclusions: Early interventions after AVB may slow cirrhosis progression by interrupting repeated bleeding, inflammation and decompensation cycles. Future studies should standardize progression endpoints, including MELD-Na change, ACLF occurrence, readmission, recurrent bleeding and transplant-free survival.

Hali tarjima qilinmagan